Clopidogrel inhibit platelet aggregation by?
Correct Answer: Inhibits ADP
Description: ANSWER: (C) Inhibits ADPREF: Goodman and Gillmans 11TH ed, Page 972TICLOPIDINE The agonists of purinergic receptors are extracellular nucleotides. Platelets contain two purinergic receptors, P2Y1 and P2Y12; both are GPCRs for ADR The ADP-activated platelet P2Y1 receptor couples to the Gq-PLC-IP3-Ca2+ pathway and induces a shape change and aggregation. Activation of the P2Y12 receptor by ADP couples via Gi to inhibit adenylyl cyclase, resulting in lower levels of cyclic AMP and thereby less cyclic AMP-dependent inhibition of platelet activation. Apparently; both receptors must be stimulated for platelet activation, and inhibition of either receptor is sufficient to block platelet activation. Ticlopidine (TICLID) is a thieno pyridine that inhibits the P2Y12 receptor.CLOPIDOGREL The thieno pyridine dopidogrel (PLAVIX) is closely related to ticlopidine and appears to have a slightly more favorable toxicity profile with less frequent thrombocytopenia and leukopenia, although TTP has been reportedABCIXIMAB Abciximab (REOPRO) is the Fab fragment of a humanized monoclonal antibody directed against the IIa3h receptor.ASPIRIN: In platelets, the major cyclooxygenase product is thromboxane A2, a labile inducer of platelet aggregation and a potent vasoconstrictor. Aspirin blocks production of thromboxane A2 by acetylating a Ser residue near the active site of platelet cyclooxygenase (COX-1).
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now